Efficacy and Tolerability of Ciprofloxacin Dry Powder for Inhalation (Ciprofloxacin DPI) in Bronchiectasis (Non-CF Etiology): Results From the Phase III RESPIRE 1 Study

Authors:
  • ASAnthony De Soyza
    Anthony De Soyza
  • TATimothy Aksamit
    Timothy Aksamit
  • TBTiemo-Joerg Bandel
    Tiemo-Joerg Bandel
  • MCMargarita Criollo
    Margarita Criollo
  • JEJ. Stuart Elborn
    J. Stuart Elborn
  • UKUlrike Krahn
    Ulrike Krahn
  • MLMaxine Lau
    Maxine Lau
  • EOElisabeth Operschall
    Elisabeth Operschall
  • EPEva Polverino
    Eva Polverino
  • KWKevin Winthrop
    Kevin Winthrop
  • RWRobert Wilson
    Robert Wilson

Abstract
No abstract available